Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 3
2007 3
2008 6
2009 16
2010 8
2011 12
2012 19
2013 19
2014 23
2015 21
2016 23
2017 19
2018 16
2019 11
2020 32
2021 31
2022 25
2023 28
2024 36
2025 19
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
Targeting mechanisms of tailed bacteriophages.
Nobrega FL, Vlot M, de Jonge PA, Dreesens LL, Beaumont HJE, Lavigne R, Dutilh BE, Brouns SJJ. Nobrega FL, et al. Among authors: lavigne r. Nat Rev Microbiol. 2018 Dec;16(12):760-773. doi: 10.1038/s41579-018-0070-8. Nat Rev Microbiol. 2018. PMID: 30104690 Review.
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.
Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, Pirnay JP, Merabishvili M, De Munter P, Peetermans WE, Dupont L, Van Gerven L, Metsemakers WJ. Uyttebroek S, et al. Among authors: lavigne r. Lancet Infect Dis. 2022 Aug;22(8):e208-e220. doi: 10.1016/S1473-3099(21)00612-5. Epub 2022 Mar 3. Lancet Infect Dis. 2022. PMID: 35248167
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.
Pirnay JP, Djebara S, Steurs G, Griselain J, Cochez C, De Soir S, Glonti T, Spiessens A, Vanden Berghe E, Green S, Wagemans J, Lood C, Schrevens E, Chanishvili N, Kutateladze M, de Jode M, Ceyssens PJ, Draye JP, Verbeken G, De Vos D, Rose T, Onsea J, Van Nieuwenhuyse B; Bacteriophage Therapy Providers; Bacteriophage Donors; Soentjens P, Lavigne R, Merabishvili M. Pirnay JP, et al. Among authors: lavigne r. Nat Microbiol. 2024 Jun;9(6):1434-1453. doi: 10.1038/s41564-024-01705-x. Epub 2024 Jun 4. Nat Microbiol. 2024. PMID: 38834776 Free PMC article.
Bacteriophages of Pseudomonas.
Ceyssens PJ, Lavigne R. Ceyssens PJ, et al. Among authors: lavigne r. Future Microbiol. 2010 Jul;5(7):1041-55. doi: 10.2217/fmb.10.66. Future Microbiol. 2010. PMID: 20632804 Review.
Implementation challenges of personalised phage therapy.
Djebara S, Lavigne R, Pirnay JP. Djebara S, et al. Among authors: lavigne r. Lancet. 2025 May 31;405(10493):1901-1903. doi: 10.1016/S0140-6736(25)00737-8. Lancet. 2025. PMID: 40449960 No abstract available.
Editorial overview: There and back again: a phage's tale.
Frunzke J, Lavigne R. Frunzke J, et al. Among authors: lavigne r. Curr Opin Microbiol. 2024 Aug;80:102518. doi: 10.1016/j.mib.2024.102518. Epub 2024 Jul 23. Curr Opin Microbiol. 2024. PMID: 39047311 No abstract available.
Combination of bacteriophages and vancomycin in a co-delivery hydrogel for localized treatment of fracture-related infections.
Chen B, Ponce Benavente L, Chittò M, Post V, Constant C, Zeiter S, Nylund P, D'Este M, González Moreno M, Trampuz A, Wagemans J, Lavigne R, Onsea J, Richards RG, Metsemakers WJ, Moriarty TF. Chen B, et al. Among authors: lavigne r. NPJ Biofilms Microbiomes. 2024 Aug 29;10(1):77. doi: 10.1038/s41522-024-00552-2. NPJ Biofilms Microbiomes. 2024. PMID: 39209878 Free PMC article.
343 results